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Abstract 
Cyclin A accumulates at the onset of S phase, remains high during G2 and 
early mitosis and is degraded at prometaphase. Here, we report that cyclin A 
directly interacts with the acetyltransferase P/CAF and is acetylated at 
lysines 54, 68, 95 and 112. Maximal acetylation occurs simultaneously to 
ubiquitylation at mitosis, indicating a role of acetylation on cyclin A 
stability. A non-acetylatable mutant in which these lysines were substituted 
by arginines (cycA 4R) cannot be ubiquitylated, is more stable than cycA 
WT and arrests cell cycle at mitosis. Despite of that, it interacts with the 
proteins needed for its degradation (cdks, Cks, Cdc20, Cdh1 and APC/C). 
CycA 4R shows higher affinity for cdks than cycA WT and cycA 4R-cdk 
complexes display higher kinase activity than control complexes. All these 
results indicate that cyclin A acetylation at specific lysines is crucial for 
cyclin A stability and also plays a role in the regulation of cyclin A-cdk 
activity. 
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Introduction 
Cell cycle progression is governed by the family of cyclin dependent kinases 
(cdks) (Morgan, 1997). Their activities are regulated by binding to 
regulatory subunits called cyclins, phosphorylation and binding to inhibitory 
proteins (Sherr and Roberts, 1999). During cell cycle, specific pairs of 
cyclin-cdks are formed and activated. Cdk1 together with cyclins A and B 
governs G2/M transition. G1 progression is under the control of cyclin D-
cdk4/6. Cyclin E-cdk2 triggers DNA synthesis and cyclin A-cdk2 drives S 
phase progression (Malumbres and Barbacid, 2005). Whereas the levels of 
most cdks are relatively constant during cell cycle those of cyclins fluctuate, 
and in that way, they bind to and activate specific cdks. 
Cyclin A levels are low during G1 but they increase at the onset of S 
phase, when it contributes to the stimulation of DNA synthesis (Rosenberg 
et al., 1995; Resnitzky et al., 1995). The amount of cyclin A remains high 
after S phase and in early mitosis when, by associating with cdk1, it drives 
the initiation of chromosome condensation and possibly nuclear envelope 
breakdown (Furuno et al., 1999; Pagano and Draetta, 1991; Gong et al., 
2007). It is destroyed during prometaphase by the Anaphase Promoting 
Complex/Cyclosome (APC/C) via proteasome (den Elzen and Pines, 2001).  
Cyclin B levels rise during G2 and then it binds to cdk1. This complex 
promotes the completion of chromosome condensation and spindle 
assembly, thus driving cell cycle progression until metaphase. Cyclin B is 
degraded during metaphase, significantly later than cyclin A (Hagting et al., 
2002). Because each cyclin is responsible for the phosphorylation of a 
specific subset of cdk substrates, it is expected that after their degradation 
their specific substrates would be dephosphorylated. Thus, the ordered 
destruction of the different cyclins helps to order the sequence of events in 
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late mitosis (Bloom and Cross, 2007). In fact, on time degradation of cyclins 
A and B is a key event for mitosis progression and non-degradable mutants 
of cyclin A cause cell arrest in metaphase, whereas those of cyclin B block 
cells during anaphase (Parry and O'Farrell, 2001; Sullivan and Morgan, 
2007). 
The signals that trigger cyclin A degradation at prometaphase are still 
a matter of controversy. Degradation is induced by APC/C bound to the 
targeting subunit Cdc20 (APC/CCdc20) that is activated by phosphorylation 
by cyclin B-cdk1. Cyclin A degradation is spindle-checkpoint independent 
and thus, it starts as soon as APC/CCdc20 is activated (den Elzen and Pines, 
2001; Geley et al., 2001). In contrast, cyclin B1 degradation by APC/CCdc20 
is sensitive to the spindle assembly checkpoint. Therefore, at prometaphase 
unattached sister chromatids generate signals that allow inhibitory 
components of the spindle-assembly checkpoint, such as Mad2, to bind to 
Cdc20 and block its ability to interact with cyclin B1 (Fang et al., 1998; 
Sudakin et al., 2001). Moreover, a recent report indicates that to maintain the 
cell cycle arrest induced by the spindle assembly checkpoint, Cdc20 must be 
ubiquitylated and degraded(Nilsson et al., 2008). Only when all chromatids 
are attached to the mitotic spindle at metaphase, the spindle-assembly 
checkpoint becomes inactivated and then cyclin B1 can be degraded. This 
different behaviour of cyclin A and cyclin B degradation by the same 
APC/C complex indicates that distinct signals participate in targeting these 
cyclins for ubiquitylation and the subsequent degradation during mitosis 
(Geley et al., 2001).  
In general, cyclins have a “destruction box” which is a sequence that 
is recognized by the ubiquitylation machinery in order to degrade these 
proteins (Glotzer et al., 1991). Cyclin A also has an extended “destruction 
 5
box” that includes aa 47-72 (Klotzbucher et al., 1996). However, in order to 
totally avoid cyclin A ubiquitylation and degradation the first 171 aa of 
cyclin A must be eliminated, revealing that in addition to the extended 
“destruction box” more sequences from the amino terminus are needed for 
cyclin A degradation (Fung et al., 2005). Moreover, the association of cyclin 
A to its cdk partner is needed for its degradation, suggesting that Cdc20 
binds to cyclin A through an extended motif that includes its amino terminus 
but also its cdk partner (Wolthuis et al., 2008). 
Here we report that cyclin A can be acetylated in vivo and in vitro by 
the acetyltransferase P/CAF at four specific lysine residues located in its 
amino terminus. When these residues are substituted by arginines, cyclin A 
cannot be ubiquitylated, is much more stable and causes cell cycle arrest at 
G2/M. Therefore, our results indicate that acetylation is a critical signal in 
the regulation of cyclin A degradation.   
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Results 
The putative in vivo acetylation of cyclin A was analyzed in HCT116 cells 
transfected with HA-cyclin A. By immunoprecipitation (IP) with anti-HA 
antibodies followed by western blotting (WB) with anti-acetylated lysines 
(acetylK), we observed that cyclin A was acetylated in the cells (Figure 1a). 
We subsequently aimed to identify the acetyltransferases that could be 
responsible for this acetylation. Thus, in vitro assays, using GST-cyclin A as 
a substrate and different acetyltransferases as enzymes were performed. As 
shown in Figure 1b, cyclin A was acetylated by P/CAF but not by CBP or 
Tip60. To further determine whether P/CAF was also involved in the in vivo 
acetylation of cyclin A, cells were transfected with Flag-P/CAF and HA-
cyclin A and treated with control or P/CAF-specific siRNAs. We then 
performed IP on cell extracts with anti-HA and the levels of cyclin A 
acetylation were determined by WB. Results revealed that the decrease of 
P/CAF strongly reduced cyclin A acetylation (Figure 1c), indicating a role of 
P/CAF in the in vivo acetylation of cyclin A. 
Among other regulatory functions, acetylation of lysine residues 
might affect protein stability in different ways. Thus, we decided to 
investigate whether acetylation could participate in the regulation of cyclin 
A stability. Cyclin A degradation largely depends on its N-terminal region 
and the lysine residues involved in cyclin A ubiquitylation and degradation 
are located in the first 171 aa of its sequence (Figure 2a) (den Elzen and 
Pines, 2001; Geley et al., 2001). To study whether the acetylation sites were 
located in this cyclin A region that contains 12 lysines, in vitro spot mapping 
assays were performed. Thus, 13 peptides (each one containing one or two 
consecutive lysines) belonging to this N-terminal region of cyclin A were 
synthesized and spotted on a membrane that was subjected to acetylation 
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assays with P/CAF (supplementary Figure S1). An acetylatable peptide from 
histone H3 was used as a control. Results indicated that peptides containing 
K54, K68, K95 and K112 were acetylated (Figure 2b). To analyze whether 
these lysines were the major acetylation sites in the full length protein, we 
generated a cyclin A mutant in which lysines 54, 68, 95 and 112 were 
substituted by arginines (cycA 4R). This mutant was used for in vitro 
acetylation assays with P/CAF. Results indicated that differently from cyclin 
A WT (cycA WT) that was clearly acetylated by P/CAF, cycA 4R was not 
(Figure 2c).  Finally, to further determine whether these four lysines were 
the major in vivo acetylation sites, cells were tranfected with Flag-cycA WT 
or Flag-cycA 4R, subsequently subjected to IP with anti-Flag and then 
cyclin A acetylation was determined by WB. Results revealed that cycA WT 
was acetylated whereas the mutant cycA 4R was not, indicating that these 
four lysines are the major in vivo acetylation sites (Figure 2d).   
The putative in vivo interaction between cyclin A and P/CAF was first 
analyzed by fluorescence microscopy in CFP-cyclin A and YFP-P/CAF 
transfected cells. Results showed that both proteins co-localized in the 
nucleus (Figure 3a). The interaction between both proteins was further 
determined by IP experiments with anti-HA in cells co-transfected with 
YFP-P/CAF and HA-cyclin A. Subsequent WB analysis demonstrated the 
co-immunoprecipitation of cyclin A, P/CAF and cdk2 (Figure 3b). Finally, 
Surface Plasmon Resonance analyses demonstrated the direct association 
between cyclin A and P/CAF (Figure 3c).  We were also interested in 
determining the interaction between cyclin A and P/CAF during the cell 
cycle. For that purpose we first analyzed the levels of cyclin A and P/CAF in 
cells synchronized at different phases of the cell cycle. We observed that the 
levels of P/CAF were high during S phase and G2/M, decreased at 
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metaphase and remained low during G1. This behaviour was similar to that 
observed for cyclin A (Figure 3d, left panel). Cdk2 was detected overall the 
cell cycle although the levels slightly varied depending on the cell cycle 
phase. To determine the interaction between cyclin A and P/CAF, IP 
experiments with anti-HA were performed in cells transfected with YFP-
P/CAF and HA-cyclin A. WB analysis of the immunoprecipitates indicated 
that cyclin A and P/CAF mostly interacted during S phase and G2/M, when 
both proteins were most abundant. At these specific points of the cell cycle 
cyclin A also interacted with cdk2. We also aimed to determine the 
acetylation status of cyclin A. Interestingly, maximal acetylation of cyclin A 
was observed during G2/M although the protein was also acetylated during S 
phase (Figure 3d, right panel).  
To study the role of acetylation on cyclin A stability, we determined 
the half-life of cycA WT and cycA 4R in transfected cells. Figure 4a shows 
that the half-life of cycA WT is of around 6 h whereas that of cycA 4R is 
much longer. As it has been reported that non-degradable forms of cyclin A 
(lacking a part of the N-terminus) cause arrest of cells in metaphase (Geley 
et al., 2001; Fung et al., 2005), we aimed to study the effect of the cycA 4R 
mutant on cell cycle progression. FACS analysis revealed a substantial block 
in G2/M in cells transfected with the cycA 4R mutant, whereas only a slight 
effect was observed in cells transfected with cycA WT (Figure 4b).  
We further explored the possibility that the increased stability of cycA 
4R could be due to defects in its ubiquitylation. Thus, in vivo ubiquitylation 
assays were performed. Cells were transfected with HA-ubiquitin plus Flag-
cycA WT or Flag-cycA 4R, then subjected to IP with anti-Flag, and finally 
the ubiquitylation levels were analyzed by WB with anti-Flag and anti-HA. 
Results indicated that cycA WT was clearly ubiquitylated whereas 
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ubiquitylation of cycA 4R was strongly reduced (Figure 5a). The low levels 
of ubiquitylation and degradation shown by cycA 4R could be due to two 
different possibilities: 1) these four lysines are actually ubiquitylation sites 
or 2) these four lysines are acetylation sites needed for the subsequent 
ubiquitylation of other lysines. To discriminate between these two 
possibilities we studied the in vivo ubiquitylation of Flag-cycA 4Q, a mutant 
in which lysines 54, 68, 95 and 112 of cyclin A were substituted by 
glutamines. This form is considered to be a pseudoacetylated mutant because 
of the structure similarity between glutamine (Q) and the acetylated-lysine 
residue (Hecht et al., 1995; Li et al., 2002). Results indicated that differently 
from cycA 4R, the mutant cycA 4Q was ubiquitylated similarly to cycA WT 
(Figure 5a). Interestingly, the half-life of cycA 4Q is shorter than that of 
cycA 4R but not as short as that of cycA WT, indicating that cycA 4Q can 
be degraded although not so efficiently as cycA WT (supplementary Figure 
S2b). Therefore, these results indicate that K54, K68, K95 and K112 are not 
ubiquitylation sites but acetylation sites needed for the ubiquitylation of 
other lysines and for the subsequent degradation of cyclin A.  
Next we analyzed the acetylation and ubiquitylation of cyclin A 
during cell cycle. Thus, Flag-cycA WT-transfected cells were synchronized 
by a double thymidine block and subjected to IP with anti-Flag at different 
times after the release of the blockade. When WB with anti-acetylK was 
performed, a peak of cyclin A acetylation was observed at 4-6 h after the 
release (Figure 5b, bottom panel). Interestingly, during the same period of 
time a peak of cyclin A ubiquitylation was also observed (Figure 5b, upper 
panel). The simultaneous acetylation and ubiquitylation of cyclin A supports 
that acetylation is involved in cyclin A ubiquitylation and degradation. 
FACS analysis revealed that under our experimental conditions at 4-6 h after 
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the release of the double-thymidine block cells are in mitosis (supplementary 
Figure S3).  
We further aimed to analyze the mechanisms underlying the 
decreased ubiquitylation of cycA 4R. It is known that to be degraded cyclin 
A has to form a cyclin A-Cdk-Cks complex that is recruited to the 
phosphorylated APC/C by its Cks protein. Cdc20 attached to this complex 
causes cyclin A to be degraded (Wolthuis et al., 2008). Thus, we analyzed 
the interactions of Flag-cycA WT and Flag-cycA 4R with Cdc20, Cdh1, 
APC3, Cks1/2, cdk1 and cdk2 in asynchronously growing cells. Results 
showed that the interaction with Cdc20 and APC3 was similar in both cases 
but cycA 4R showed an increased interaction with cdk1, cdk2, Cks and 
Cdh1 (Figure 6a). The interaction between the mutant cycA 4R and Cdc20 
was further confirmed by IP experiments with anti-Flag in cells transfected 
with Flag-Cdc20 plus CFP-cycA WT or CFP-cycA 4R (Figure 6b, upper 
panel). Moreover, the increased interaction of Cdh1 with cycA 4R was also 
confirmed by IP experiments with anti-HA in cells transfected with HA-
Cdh1 plus Flag-cycA WT or Flag-cycA 4R (Figure 6b, bottom panel). 
Experiments carried out in cells synchronized in S phase or G2/M revealed 
that the interactions of cycA WT or cycA 4R with these proteins at these 
specific points are similar to those observed in asynchronously growing cells 
(supplementary Figure S4).  
The increased interaction of cycA 4R with cdk1 and cdk2 is of 
particular interest because it might affect their kinase activity. To analyze 
this possibility, cells transfected with Flag-cycA WT or Flag-cycA 4R were 
subjected to IP with anti-Flag and the associated cdk activity was determined 
in the immunoprecipitates. We observed that cycA 4R-cdk complexes 
display higher kinase activity than that of cycA WT-cdk complexes (Figure 
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6c). When cells were subjected to IP with anti-cdk2 we also observed an 
increased association of cycA 4R with cdk2 respect to that shown by cycA 
WT, and also a higher kinase activity in the cycA 4R-cdk2 complexes 
(Figure 6d). So, in addition to the role in cyclin A stability, lysines 54, 68, 
95 and 112 also play a role in the regulation of cyclin A interaction with cdk 
and its associated kinase activity. 
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Discussion 
The different timing of cyclin A and cyclin B degradation at mitosis and the 
diverse sensitivity of these cyclins to the spindle assembly checkpoint 
indicates that specific mechanisms target each one of these cyclins for 
degradation (van Leuken et al., 2008). We report here that cyclin A 
acetylation by the acetyltranferase P/CAF participates in the signalling 
pathway that targets cyclin A for degradation at early mitosis. Acetylation is 
a post-translational modification occurring at the Nε-amino-group of lysines 
that might regulate protein functions in many different ways as for instance, 
protein-protein and protein-DNA interactions and protein stability. Lately, a 
number of reports have revealed that lysine acetylation might act as a direct 
signal enhancing protein degradation for proteins such as E2F1 (Galbiati et 
al., 2005), HIF-1α (Jeong et al., 2002), SV40 T antigen (Shimazu et al., 
2006), and pRB (Leduc et al., 2006). Moreover, the interplay between lysine 
acetylation and ubiquitylation has been reinforced by the evidence that at 
least four acetyltransferases (p300, CBP, P/CAF and TAF1) possess intrinsic 
ubiquitin activating/conjugating or ligase activities (Sadoul et al., 2008).  
We report here that P/CAF acetylates cyclin A at lysines K54, K68, 
K95 and K112 and that these lysines are the major acetylation sites both in 
vivo and in vitro.  These specific residues are located in the amino terminal 
domain of cyclin A that has been involved in the stability of the protein 
(Wolthuis et al., 2008). In fact, two of these lysines, K54 and K68 were 
already described as important residues for the ubiquitylation and 
degradation of cyclin A. Specifically, the authors reported that substitution 
of  K37, K54 and K68 by arginines generates a more stable cyclin A but this 
mutant was still ubiquitylated (Fung et al., 2005).  
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Our results indicate that lysines K54, K68, K95 and K112 are critical 
residues for ubiquitylation and degradation of cyclin A. A possible role of 
these lysines in these processes is to act as acetylation sites needed for the 
subsequent ubiquitylation of other lysine residues. This is supported by the 
evidence that the ubiquitylation of the non-acetylatable mutant cycA 4R is 
strongly reduced whereas the pseudoacetylated mutant cycA 4Q was 
ubiquitylated similarly to cycA WT. As glutamines cannot be ubiquitylated, 
the ubiquitylation sites in the cycA 4Q mutant must be other lysines 
probably located in the amino terminus of cyclin A. Thus, these results 
suggest that likely cyclin A acetylation at these specific lysines signals this 
protein for the subsequent ubiquitylation and degradation. 
According to our observations, P/CAF is the principal histone 
acetyltransferase involved in cyclin A acetylation. In addition to acetylate 
histones, P/CAF also participates in the reversible acetylation of various 
transcriptional regulators as the general transcription factors TFIIEβ and 
TFIIF (Imhof et al., 1997) and the sequence-specific transcription factors 
E2F1 (Martinez-Balbas et al., 2000), c-myc (Patel et al., 2004), myo D 
(Patel et al., 2004) and p53 (Gu and Roeder, 1997; Sakaguchi et al., 1998). It 
has been implicated in many important cellular processes such as 
transcription, differentiation, proliferation and apoptosis (Schiltz and 
Nakatani, 2000). In the cell P/CAF is a subunit of multiprotein complexes 
that posses global histone acetylation activity and locus-specific co-activator 
functions together with acetyl transferase activity on non-histone susbtrates 
(Nagy and Tora, 2007). Recently, it has been described that in addition to 
acetylate p53, the intrinsic ubiquitylation activity of P/CAF controls the 
stability of the oncoprotein Hdm2, indicating an important role of this 
acetylase in the DNA damage checkpoint (Linares et al., 2007).  
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Interestingly, the levels of P/CAF oscillate during cell cycle similarly 
to those of cyclin A. They are low at G1, increase during S phase and remain 
high during G2 and early mitosis to finally decrease before metaphase. As 
the decrease of cyclin A is produced by degradation by the APC/CCdc20 
complex, the similar behaviour of P/CAF suggests that it could also be an 
APC/CCdc20 substrate. However, this is something that needs to be 
investigated.  
Cyclin A associates with P/CAF during S phase and this interaction is 
maintained until early mitosis, then before metaphase this complex is 
disrupted. Concomitant to its association with P/CAF, cyclin A becomes 
acetylated. A more detailed time-course analysis indicates that cyclin A 
acetylation increases at early mitosis simultaneously to cyclin A 
ubiquitylation. All these data support that acetylation by P/CAF targets 
cyclin A for its ubiquitylation.    
To be degraded cyclin A has to be bound to a cdk subunit which in 
turn has to be associated with a Cks protein. This cyclin A-cdk-Cks complex 
is then recruited to the phosphorylated APC/C by its Cks subunit. The 
Cdc20 attached to cyclin A causes cyclin A to be degraded regardless of the 
spindle checkpoint being active or not (Wolthuis et al., 2008). Thus, a 
possibility is that cyclin A acetylation at these specific lysines might be 
required for the interaction with some of these proteins of the ubiquitylation 
machinery. However, the analysis of the interactions of the non-acetylatable 
mutant cycA 4R with the proteins of the APC/CCdc20 ubiquitylation complex 
ruled out this possibility because this mutant retains the ability to interact 
with all the proteins of the complex (Cdc20, Cdh1, APC3, cdks and Cks). 
Thus, the lack of ubiquitylation is not due to a reduced ability to form 
ubiquitylation complexes. A possible interpretation of these results is that 
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acetylation of lysines 54, 68, 95 and 112 is needed for the correct 
incorporation of ubiquitin molecules on specific sites of cyclin A.   
An unexpected result was the observation that the levels of cdk1, cdk2 
and Cks associated with cycA 4R are much higher than those bound to cycA 
WT. These results might be interpreted in the sense that cycA 4R displays a 
much higher affinity for these proteins than cycA WT. As Cks does not 
directly interact with cyclin A but associates with the cdk subunits, probably 
the higher affinity of cycA 4R for this protein is a consequence of its 
increased affinity for the cdks.  The increased affinity of cycA 4R for the 
cdks is accompanied by a higher activity of these complexes compared to 
that displayed by cycA WT-cdks.  Likely, this increased kinase activity is 
due to the fact that cycA 4R is able to generate more complexes with cdks 
than cycA WT does. The putative role of the augmented affinity of cycA 4R 
for cdks and the subsequent elevated kinase activity of these complexes on 
the ubiquitylation block still remains unknown. 
Likely, this increased kinase activity is due to the fact that cycA 4R is 
able to generate more complexes with cdks than cycA WT does. 
As a summary, results presented here reveal that acetylation at 
specific lysines is a new mechanism that targets cyclin A for degradation at 
early mitosis. In addition to that, our results also revealed an unexpected 
new mechanism for the regulation of cdk activity that depends on the 
integrity of four specific lysines of cyclin A. 
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Materials and methods 
 
Plasmids 
cDNA of wild type cyclin A was cloned into pGEX6P1, pEFHA, pcDNA3-
Flag and pECFP-C1 vectors. CycA 4R and 4Q mutants were generated by 
site-directed mutagenesis. pCX-Flag-P/CAF, pGEX2TKP-HATP/CAF (352-
658), pGEX4T2-P/CAF (full length), pGEX2T-CBP and pGEX2T-Tip60 
were a kind gift from MA. Martínez-Balbás. pcDNA3.1-HA-Cdh1 and Flag-
Cdc20 were a kind gift from M. Pagano. P/CAF shRNA and control shRNA 
were purchased from Sigma. 
 
Antibodies and reagents 
Antibodies against cyclin A (H-432), cdk2 (M-2), Cdc20 (H175) and Cks1/2 
(FL-79) were purchased from Santa Cruz Biotechnology. Anti-Cdh1 (34-
2000) was purchased from Zymed. Anti-acetylK (#9441) and anti-phospho-
histone H3 (Ser 28) (#9713) were from Cell Signaling. Antibodies against 
Flag (F7425), HA (H6908) and P/CAF (P7493) were purchased from Sigma, 
and APC3/Cdc27 (ab10538) from Abcam. For IPs we used monoclonal anti-
HA agarose and monoclonal anti-Flag M2 affinity gel from Sigma. 
[14C]acetylCoA was purchased from Perkin Elmer. Thymidine, Nocodazol 
and Cycloheximide were from Sigma. ALLN was from Calbiochem. 
 
Protein purification and in vitro acetylation 
Protein expression and purification was performed as described (Canela et 
al., 2006). Acetylase assays were performed as described (Martinez-Balbas 
et al., 2000). For cyclin A acetylation assays, 1-10 μl of the different 
acetylases (5,000-10,000 cpm activity on histones) were incubated with 6 
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μM of purified GST or GST-cyclin A and 0.02 μCi [14C]acetylCoA. For the 
spot-mapping experiment, the membrane was incubated in 3 ml of HAT 
buffer (50 mM Tris-HCl pH 8, 500 mM NaCl, 0.1 mM EDTA, 5% glycerol, 
0.1% NP-40) in the presence of GST-HATP/CAF and [14C]acetylCoA, for 30 
min at 30ºC. Then, the membrane was washed, dried and subjected to 
autoradiography. 
 
Immunoprecipitation 
Cells were lysed in RIPA buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 
1% NP-40, 0.5% Sodium deoxycholate, 0.1%SDS, 1 mM EDTA, 1 mM 
DTT, 1 mM PMSF, 0.1 mM Na3VO4, 0.5 μg/μl aprotinin, 10 μg/μl 
leupeptin) for 30 min on ice. After centrifugation, lysates (0.2-2 mg of 
protein) were incubated with Flag or HA agarose beads for 2 h at 4ºC. After 
3 washes with RIPA buffer, Laemmli buffer was added to the samples and 
they were electrophoresed. 
 
Surface Plasmon Resonance experiments 
The Surface Plasmon Resonance analysis was performed at room 
temperature using a Biacore T100 (Biacore International AB). P/CAF 
purified protein was immobilized on a carboxymethylated dextran sensor 
chip (CM5) using the amine coupling method as described by the 
manufacturer. A blank immobilization was performed using the same 
method and was used as the reference surface. Purified full-length cyclin A 
was diluted in HBS-EP buffer (Biacore International AB) and was injected 
over the flow cells at a flow rate of 30 μl/min for 60 s. Following a 
dissociation time of 120 s, final regeneration of the surface was performed 
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with a short pulse of 0.05% (w/v) SDS. The interaction between P/CAF and 
cyclin A was detected and presented as a sensorgram by plotting resonance 
units against time.  
 
Cell culture, synchronization and treatments 
Cells were grown in Dulbecco's modified Eagle's medium supplemented 
with 10% fetal calf serum. Transfected synchronized cells were obtained as 
described (Donzelli et al., 2002). Specific experiments were performed with 
cells that were cultured in the presence of 10 μg/ml cycloheximide. 
 
Flow citometry analyses 
Cells were fixed with 70% cold ethanol for 2 h at 4ºC, washed with PBS, 
and finally incubated with 50 μg/ml of propidium iodide (Sigma) and 200 
μg/ml RNase for 30 min at room temperature. Analysis of DNA content was 
carried out in a BD Biosciences FACS Canto II. Data was analysed with 
WinMDI 2.9 software.  
 
In vivo ubiquitylation assays 
Cells were transfected with indicated plasmids. 24 h after transfection, cells 
were replated and treated with 100 μM ALLN for 16 h. Then, cells were 
harvested and subjected to IP. 
 
Immunoprecipitation and kinase assays 
After three washes in RIPA buffer and two in kinase buffer (50 mM Hepes 
pH 7.4, 2.5 mM EGTA, 10 mM MgCl2) immunoprecipitates were 
resuspended in a final volume of 30 μl of kinase buffer containing 12.5 μM 
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ATP, 1 μCi of [32P]ATP, 2 mM dithiothreitol, and 2 μg of histone H1 for 30 
min at 30°C. Reactions were stopped by the addition of Laemmli buffer. The 
samples were then electrophoresed on 12% SDS-polyacrylamide gels and 
then stained with Coomassie Blue and dried. The radioactivity associated to 
the gels was detected with a PhosphorImager. 
 
Supplementary information is available at the oncogene’s web site 
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Legends to the Figures 
 
Figure 1 Cyclin A is acetylated by P/CAF in vivo and in vitro. (a) HCT116 
cells transfected with HA-cyclin A were subjected to IP with anti-HA or IgG 
as a control, followed by WB with anti-HA or anti-acetylK. (b) Purified 
GST-cyclin A was subjected to in vitro acetylation assays using the catalytic 
domain of P/CAF (GST-HATP/CAF), GST-CBP or GST-Tip60 in the 
presence of [14C]acetylCoA. Purified GST was used as a negative control 
substrate. In the assays with P/CAF or Tip60 their autoacetylation was used 
as a positive control, whereas in the case of CBP, histones were used as a 
positive control substrate. Acetylated proteins were visualized by 
autoradiography (upper panel). A loading control gel was stained with 
coomassie blue (bottom panel). (c) HCT-116 cells were transfected with 
Flag-P/CAF, HA-cyclin A and control or P/CAF siRNA. Extracts were 
prepared and expression of P/CAF was analysed by WB (left panel). IPs 
against HA or IgG as a control were performed with part of the extracts 
followed by western blot with anti-HA or anti-acetylK (right panel). 
 
Figure 2 Cyclin A is acetylated at lysines 54, 68, 95 and 112. (a) Schematic 
representation of cyclin A lysine residues and domains. (b) Thirteen peptides 
including one or two consecutive lysines from the cyclin A fragment 
including aa 1-171, were spotted on a membrane (see also Fig S1). As a 
positive control a peptide from histone H3 was added. The membrane was 
subjected to in vitro acetylation assays with P/CAF and [14C]acetylCoA. 
Acetylation was visualized by autoradiography. (c) Purified GST-cycA WT 
and GST-cycA 4R were used in in vitro acetylation assays with P/CAF. 
Acetylation was visualized by autoradiography (left panel). A loading 
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control gel was stained with coomassie blue (right panel). (d) HeLa cells 
were transfected with Flag-cycA WT or Flag-cycA 4R. Cell extracts were 
subjected to IP with anti-Flag followed by WB with anti-Flag and anti-
acetylK. 
 
Figure 3 Cyclin A is acetylated and interacts with P/CAF at S and G2/M 
phases of the cell cycle. (a) COS cells were transfected with CFP-cyclin A 
and YFP-P/CAF and co-localization of both proteins was studied by 
fluorescence microscopy. (b) HeLa cells were transfected with HA-cyclin A 
and YFP-P/CAF. Cell extracts were subjected to IP using HA or IgG as a 
control followed by WB with antibodies against HA, P/CAF and cdk2. A 
sample of cell lysate (input) was used as a control. (c) The putative direct 
interaction between P/CAF and cyclin A was studied by Surface Plasmon 
Resonance as described in methods section. P/CAF was fixed on the matrix 
and cyclin A was left to circulate on the chip. The interaction was 
represented in the sensorgram. (d) HeLa cells were transfected with HA-
cyclin A and YFP-P/CAF and synchronized by a double-thymidine block or 
nocodazol as described in methods section. Then, the levels of P/CAF, 
cyclin A and cdk2 were determined by WB (left panel). To confirm the time 
of mitosis a western blot with antibodies against phosphorylated histone H3 
was performed (bottom, left panel). Cell extracts were subjected to IP with 
anti-HA and the amount of P/CAF, cyclin A, acetylated cyclin A and cdk2 
was analyzed by WB (right panel).   
 
Figure 4 CycA 4R is much more stable than cycA WT and induces cell 
cycle arrest at G2/M. (a) HeLa cells were transfected with Flag-cycA WT or 
Flag-cycA 4R, treated with cyclohexymide (CHX) and collected at different 
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times of treatment. Cyclin A levels were analyzed by western blot. Cdk2 
levels were used as a loading control. The amount of Flag-cyclin A was 
quantitated and represented in the graph. Results are the mean ± SE of 8 
independent experiments. (b) HeLa cells were mock-transfected as a control 
or transfected with CFP-cycA WT or CFP-cycA 4R. FACS analysis of the 
population of transfected cells was performed (bottom panel) and 
represented in a graph (upper panel). Control of expression of CFP-cycA 
WT and 4R is shown in Figure S2a.  
 
Figure 5 Cyclin A acetylation is simultaneous to its ubiquitylation. (a) HeLa 
cells were transfected with HA-ubiquitin plus Flag-cycA WT, Flag-cycA 4R 
or Flag-cycA 4Q and treated with the proteasome inhibitor ALLN. Then, 
they were lysed and subjected to IP with anti-Flag or IgG as a control. The 
levels of ubiquitylated cyclin A were determined by WB with anti-Flag and 
anti-HA. (b) Flag-cycA WT-transfected cells were treated with the 
proteasome inhibitor ALLN, collected at different times after the release of a 
double-thymidine block and subjected to IP with anti-Flag. Cyclin A 
ubiquitylation was determined by western blot with anti-Flag and cyclin A 
acetylation with anti-acetylK. A shorter exposure of WB anti-Flag is shown 
in the middle panel. 
 
 Figure 6 Differential interaction of cycA WT and 4R with components of 
the ubiquitylation machinery and cdk1 and cdk2. (a) 293T cells were 
transfected with Flag-cycA WT or Flag-cycA 4R, then lysed, and IPs with 
anti-Flag were performed. The presence of APC3, Cdh1, Cdc20, Cks1/2, 
cdk1 and cdk2 in the immunoprecipitates was determined by WB. (b) As 
described in (a), but co-transfecting Flag-Cdc20 with CFP-cycA WT or 4R, 
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or co-transfecting HA-Cdh1 with Flag-cycA WT or 4R. (c, d) 293T cells 
were transfected with Flag-cycA WT or 4R, lysed and immunoprecipitated 
with anti-Flag (c) or anti-CDK2 (d). Kinase assays of the 
immunoprecipitates were performed and phosphorylation of histone H1 was 
detected by PhosphorImager. Kinase activity was normalized to the amount 
of immunoprecipitated cdk2 and represented in the graphs. Results shown 
are the mean ± SE of 3 independent experiments. Asterisk indicates an 
unspecific band detected by anti-Flag antibody. 
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